Worth reading
72In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
173.7
¥100 million (year-on-year increase in net sales)Wording
Conditional
How definitive the wording is.No category-specific facts could be extracted from this document.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In Japan, oral healthcare performed strongly. Overseas, higher revenue and profit were supported by the impact of newly consolidating operations in Vietnam and Australia, a recovery in sales momentum in major markets, increased gross profit accompanying sales growth, and management focused on profitability. In the second half, however, raw material prices are expected to rise due to the situation in the Middle East. The Company will respond through price pass-through, cost reductions and more targeted promotional spending.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.